TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a Read More
November 9, 2026
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs… TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: Read More
FILES SET FOR RELEASE… DEVELOPING… (First column, 7th story, link) Related stories:Bondi Gets Jail Time Warning Over Epstein Cover-Up… Read More
Trump’s executive order moves marijuana to Schedule III, affecting 6 million patients. Cannabis stocks plunge 27% amid fears of Big Pharma Read More
US President Donald Trump wants to speed up the reclassification of marijuana, from Schedule I to Schedule III. President Donald Read More
VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (LEEF or the Company), a leading multi-state Read More
The long-awaited move will facilitate medical research and provide tax relief to the cannabis industry, but it falls far short Read More
The switch would move marijuana away from its current classification as a Schedule I drug, alongside heroin and LSD. WASHINGTON — Read More
DALLAS – On Thursday, President Donald Trump signed an executive order to reclassify marijuana as a less dangerous drug. It’s Read More
President Donald Trump has directed his administration to work as quickly as possible to reclassify marijuana as a less dangerous Read More